申请人:Bionomics Limited
公开号:US10266529B2
公开(公告)日:2019-04-23
The present invention provides crystalline Forms FUM-P3, FUM-P4, MLA-P3 and MLA-P4 of compound formula 1 and related methods of treating and/or preventing a disease, such as a central nervous system disease (e.g., an anxiety disorder), using a crystalline Form FUM-P3, FUM-P4, MLA-P3 and MLA-P4 of compound formula 1 and/or pharmaceutical compositions thereof.
本发明提供了化合物式1的结晶形式FUM-P3、FUM-P4、MLA-P3和MLA-P4,以及使用化合物式1的结晶形式FUM-P3、FUM-P4、MLA-P3和MLA-P4和/或其药物组合物治疗和/或预防疾病(如中枢神经系统疾病,如焦虑症)的相关方法。